Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685620 · ClinicalTrials.gov registry record · Phase 4
Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers
A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 4
- Development phase
- 463
- Enrollment target
NCT00685620: Completed Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00685620 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 463 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (11% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00685620, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 463 participants
- Enrollment target
Study Summary
Purpose of the project is to examine the effectiveness of Reinforcement-Based Treatment (RBT) on drug abuse and psychosocial outcomes of iner city opiate abusers who have recently completed a brief detoxification.
Interventions
- BEHAVIORAL Reinforcement Based Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2002-08 |
| Est. Completion | 2007-02 |
| Phase | Phase 4 |
What the finished NCT00685620 record still lists
NCT00685620 is an interventional study that assigns participants to a tested intervention. The registered 463 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (11% lower).
The record links to 0 conditions, and to 1 intervention - of which Reinforcement Based Treatment is the first listed.
NCT00685620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00685620 about?
NCT00685620 is a clinical study titled "Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers". Purpose of the project is to examine the effectiveness of Reinforcement-Based Treatment (RBT) on drug abuse and psychosocial outcomes of iner city opiate abusers who have recently completed a brief detoxification.
What is the current status of trial NCT00685620?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 463 participants. The study started on 2002-08. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00685620?
The interventions under investigation include: Reinforcement Based Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00685620?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00685620's enrollment target sits among peer trials
463 183rd of 2000 higher than 1,817 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT06444295 · 464 participants · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia